561
Views
8
CrossRef citations to date
0
Altmetric
Clinical Study

Hepatocyte Growth Factor in Saliva of Patients with Renal Failure and Periodontal Disease

, , , &
Pages 942-951 | Received 10 Feb 2012, Accepted 20 May 2012, Published online: 26 Jul 2012

REFERENCES

  • Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun. 1984;122:1450–1459.
  • Boros P, Miller CM. Hepatocyte growth factor: A multifunctional cytokine. Lancet. 1995;345:293–295.
  • Matsumoto K, Mizuno S, Nakamura T. Hepatocyte growth factor in renal regeneration, renal disease and potential therapeutics. Curr Opin Nephrol Hypertens. 2000;9:395–402.
  • Funakoshi H, Nakamura T. Hepatocyte growth factor: From diagnosis to clinical applications. Clin Chim Acta. 2003;327:1–23.
  • Tamura M, Arakaki N, Tsubouchi H, Takada H, Daikuhara Y. Enhancement of human hepatocyte growth factor production by interleukin-1α and -1β and tumor necrosis factor-α by fibroblasts in culture. J Biol Chem. 1993;268:8140–8145.
  • Sugiyama A, Arakaki R, Ohnishi T, . Lipoteichoic acid and interleukin 1 stimulate synergistically production of hepatocyte growth factor (scatter factor) in human gingival fibroblast in culture. Infect Immun. 1996;64:1426–1431.
  • Ohnishi T, Suwa M, Oyama T, . Prostaglandin E2 predominantly induces production of hepatocyte growth factor/scatter factor in human dental pulp in acute inflammation. J Dent Res. 2000;79:748–755.
  • Ohnishi T, Daikuhara Y. Hepatocyte growth factor/scatter factor in the development, inflammation and carcinogenesis: Its expression and role in oral tissues. Arch Oral Biol. 2003;48:797–804.
  • Ohshima M, Noguchi Y, Ito M, Maeno M, Otsuka K. Hepatocyte growth factor secreted by periodontal ligament and gingival fibroblasts is a major chemoattractant for gingival epithelial cells. J Periodont Res. 2001;36:377–383.
  • Ohshima M, Sakai A, Ito K, Otsuka K. Hepatocyte growth factor (HGF) in periodontal disease: Detection of HGF in gingival crevicular fluid. J Periodont Res. 2002;37:8–14.
  • Ohshima M, Fujikawa K, Akutagawa H, . Hepatocyte growth factor in saliva: A possible marker for periodontal disease status. J Oral Sci. 2002;44:35–39.
  • Dirschnabel AJ, Martins Ade S, Dantas SA, . Clinical oral findings in dialysis and kidney-transplant patients. Quintessence Int. 2011;42:127–133.
  • Naugle K, Darby ML, Bauman DB, Lineberger LT, Powers R. The oral health status of individuals on renal dialysis. Ann Periodontol. 1998;3:197–205.
  • Gavaldá C, Bagán JV, Scully C, . Renal hemodialysis patients: Oral, salivary, dental and periodontal findings in 105 adult cases. Oral Diseases. 1999;5:299–302.
  • Tomás I, Marinho JS, Limeres J, . Changes in salivary composition in patients with renal failure. Arch Oral Biol. 2008;53:528–532.
  • Kao CH, Hsieh JF, Tsai SC, Ho YJ, Chang HR. Decreased salivary function in patients with end-stage renal disease requiring hemodialysis. Am J Kidney Dis. 2000;36:1110–1114.
  • Klassen JT, Krasko BM. The dental health status of dialysis patients. J Can Dent Assoc. 2002;68:34–38.
  • Craig RC, Spittle MA, Levin NW. Importance of periodontal disease in the kidney patient. Blood Purif. 2002;20:113–119.
  • Postorino M, Catalano C, Martorano C, . Salivary and lacrimal secretion is reduced in patients with ESRD. Am J Kidney Dis. 2003;42:722–728.
  • Frankenthal S, Nakhoul F, Machtei EE, . The effect of secondary hyperparathyroidism and hemodialysis therapy on alveolar bone and periodontium. J Clin Periodontol. 2002;29:479–483.
  • Yamalik N, Delilbasi L, Gulay H, . The histological investigation of gingival from patients with chronic renal failure, renal transplants, and periodontitis: A light and electron microscopic study. J Periodontol. 1991;62:737–744.
  • Marakoglu I, Gursoy UK, Demirer S, Sezer H. Periodontal status of chronic renal failure patients receiving hemodialysis. Yonsei Med J. 2003;44:648–652.
  • Sugimura K, Kim T, Goto T, . Serum hepatocyte growth factor levels in patients with chronic renal failure. Nephron. 1995;70:324–328.
  • Rampino T, Libetta C, De Simone W, . Hemodialysis stimulates hepatocyte growth factor release. Kidney Int. 1998;53:1382–1388.
  • Borawski J, Myśliwiec M. Serum hepatocyte growth factor is associated with viral hepatitis, cardiovascular disease, erythropoietin treatment, and type of heparin in hemodialysis patients. Nephrol Dial Transplant. 2002;17:637–644.
  • Borawski J, Naumnik B, Myśliwiec M. Striking increase in circulating hepatocyte growth factor during enoxaparin-anticoagulated hemodialysis. Nephrol Dial Transplant. 2003;18:1680–1682.
  • Borawski J, Naumnik B, Myśliwiec M. Activation of hepatocyte growth factor/activin A/follistatin system during hemodialysis: Role of heparin. Kidney Int. 2003;64:2229–2237.
  • World Health Organization: Periodontal disease. Report of an expert committee on dental health. Int Dent J. 1961;11:544–549.
  • Löe H, Silness J. Periodontal disease in pregnancy. Prevalence and severity. Acta Odont Scand. 1963;21:533–551.
  • Saxer UP, Mühlemann HR. Motivation und Aufklärung. Schweiz Mschr Zahnheilk. 1975;85:905–1002.
  • Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odont Scand. 1964;22:112–135.
  • Kaufman E, Lamster IB. Analysis of saliva for periodontal diagnosis: A review. J Clin Periodontol. 2000;27:453–465.
  • Amano O, Matsumoto K, Nakamura T, Iseki S. Expression and localization of hepatocyte growth factor in rat submandibular gland. Growth Factors. 1994;10:145–151.
  • Wilczyńska-Borawska M, Borawski J, Kovalchuk O, Chyczewsk L, et al. Unexpected effect of haemodialysis on salivary hepatocyte growth factor. Nephrol Dial Transplant. 2005;20:2869–2870.
  • Collins AJ, Chen SC, Gilbertson DT, Foley RN. CKD surveillance using administrative data: Impact on the health care system. Am J Kidney Dis. 2009;53(Suppl. 3):S27–S36.
  • Friedewald VE, Kornman KS, Beck JD, . The American Journal of Cardiology and Journal of Periodontology editors’ consensus: Periodontitis and atherosclerotic cardiovascular disease. J Periodontol. 2009;80:1021–1032.
  • Xu F, Lu B. Prospective association of periodontal disease with cardiovascular and all-cause mortality: NHANES III follow-up study. Atherosclerosis. 2011;218:536–542.
  • Borawski J, Wilczyńska-Borawska M, Stokowska W, Myśliwiec M. The periodontal status of pre-dialysis chronic kidney disease and maintenance dialysis patients. Nephrol Dial Transplant. 2007;22:457–464.
  • Brito F, Almeida S, Figueredo CMS, . Extent and severity of chronic periodontitis in chronic kidney disease patients. J Periodont Res. 2011, doi:10.1111/j.1600-0765. 2011.01449.x
  • Thorman R, Neovius M, Hylander B. Clinical findings in oral health during progression of chronic kidney disease to end-stage renal disease in a Swedish population. Scand J Urol Nephrol. 2009;43:154–159.
  • Kanjanabuch P, Sinpitaksakul P, Chinachatchawarat S, Pacharapong S, Kanjanabuch T. Oral and radiographic findings in patients undergoing continuous ambulatory peritoneal dialysis. J Med Assoc Thai. 2011;94(Suppl. 4):S106–S112.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.